Skip to content

Clinical trials

Completed Phase 3 Autism Spectrum Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Phase 3 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20102
20111
20132
20151
20172
20181
20192
20201
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital4
The University of Hong Kong4
AbbVie2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Assaf-Harofeh Medical Center1
Assistance Publique - Hôpitaux de Paris1
Astrogen, Inc.1
Emory University1
Holland Bloorview Kids Rehabilitation Hospital1
Indiana University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder22
Autistic Disorder12
Child Development Disorders, Pervasive3
Asperger Syndrome2
Angelman Syndrome1
Attention Deficit Disorder with Hyperactivity1
Constipation1
Encopresis1
Fragile X Syndrome1
Marijuana Abuse1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.